Cargando…
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
Ferroptosis is an iron-dependent, oxidative cell death, and is distinct from apoptosis, necrosis and autophagy. In this study, we demonstrated that lysosome disrupting agent, siramesine and a tyrosine kinase inhibitor, lapatinib synergistically induced cell death and reactive oxygen species (ROS) in...
Autores principales: | Ma, S, Henson, E S, Chen, Y, Gibson, S B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973350/ https://www.ncbi.nlm.nih.gov/pubmed/27441659 http://dx.doi.org/10.1038/cddis.2016.208 |
Ejemplares similares
-
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
por: Ma, Shumei, et al.
Publicado: (2017) -
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
por: Villalpando-Rodriguez, Gloria E., et al.
Publicado: (2019) -
Prostate Cancer Cells Are Sensitive to Lysosomotropic Agent Siramesine through Generation Reactive Oxygen Species and in Combination with Tyrosine Kinase Inhibitors
por: Garcia, Emily A., et al.
Publicado: (2022) -
Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
por: Hafner Česen, M, et al.
Publicado: (2013) -
Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo
por: Jensen, Stine S., et al.
Publicado: (2017)